.jpg)
.png)
NLA News
SCOTTSDALE, Ariz.—The National Lipid Association (NLA), a nonprofit, multidisciplinary medical society focused on enhancing the practice of lipid management in clinical medicine, marks a major milestone this year with its tenth anniversary. Lipid management involves the treatment of disruptions in... more
Regeneron Pharmaceuticals, Inc. today announced that the New England Journal of Medicine (NEJM) published positive results from the Phase 3 trial of evinacumab in 65 patients with homozygous familial hypercholesterolemia (HoFH). Evinacumab is an investigational medicine that... more
Arrowhead Pharmaceuticals is proud to announce the publication of two back-to-back NEJM manuscripts in the mixed hyperlipidemia population with plozasiran (MUIR study with APOC3 target) and zodasiran (ARCHES2 study with ANGPTL3 target) following the EAS presentations by Drs. Ballantyne and... more
The National Lipid Association (NLA) was in attendance at the recent American College of Cardiology (ACC) Annual Scientific Session and Expo 2015, March 14-16, in San Diego. The meeting was dedicated to the diagnosis, prevention and treatment of cardiovascular disease, taking an interactive and... more
FOURIER Trial Reveals Significant Reduction in Cardiovascular Risk Study results indicate that evolocumab significantly reduces the risk of cardiovascular events in patients with clinically evident ASCVD WASHINGTON, D.C., March 17, 2017 — The FOURIER trial lead investigators... more
Regeneron Pharmaceuticals, Inc. and Sanofi have announced that the U.S. Food and Drug Administraion (FDA) has approved Praluent® (alirocumab) to reduce the risk of heart attack, stroke and unstable angina requiring hospitalization in adults with established cardiovascular (CV)... more
Join NLA faculty as they present “Myopathy and More: Getting Statins to Work in the Real World” at the AHA Scientific Sessions in Los Angeles on Monday, November 5 from 7:30 to 8:45 a.m. Part of the session will focus on results from the USAGE survey, the largest known consumer... more
National Lipid Association Announces Late-Breaking Abstract Presentations at NLA 2020 Virtual Scientific Sessions JACKSONVILLE, Fla. – (December 10, 2020) – The National Lipid Association announced today that it will feature three key late breaking scientific abstract presentations at... more
Recent survey shows need for triglyceride testing and improved reporting by health care providers JACKSONVILLE, Fla. (September 2014) — In response to recent survey findings, the National Lipid Association (NLA) announces a nationwide educational campaign to raise awareness within target... more
National Lipid Association Unveils New Mission to Advance Lipidology and Cardiometabolic Health JACKSONVILLE, Fla. – (May 31, 2024) - The National Lipid Association (NLA) is proud to announce its renewed mission: “To enhance the science and practice of lipidology and promote optimal... more